Tildrakizumab for the treatment of exfoliative cheilitis

Eksfolyatif keilit tedavisinde tildrakizumab

Timothy COWAN, Nada ABU ALRUB, Anna WİLSON, Mani MAKHİJA, Dedee MURRELL

Journal: Mucosa
Issue: 2023 · Cilt: 6 - Sayı: 1
Pages: 19–21
DOI: —

Abstract

Exfoliative cheilitis is an inflammatory condition that can significantly impair quality of life. This is the first reported case of an interleukin-23 inhibitor, tildrakizumab, for the treatment of a chronic, refractory case of exfoliative cheilitis.

Keywords: biyolojik, keilit, tildrakizumab, interlökin-23, dermatoloji